Status:

TERMINATED

A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding

Lead Sponsor:

Bayer

Conditions:

Uterine Fibroids and Heavy Menstrual Bleeding

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

To evaluate the safety and efficacy of vilaprisan in Japanese subjects with uterine fibroids and heavy menstrual bleeding (HMB).

Eligibility Criteria

Inclusion

  • 18 years or older
  • Diagnosis of uterine fibroid(s) documented by ultrasound at screening
  • Heavy menstrual bleeding (HMB) \>80.00 mL associated with uterine fibroid(s)
  • Good general health
  • Normal or clinically insignificant cervical smear
  • An endometrial biopsy performed during the screening period, without significant histological disorder
  • Use of an acceptable nonhormonal method of contraception starting at Visit 1 until the end of the study

Exclusion

  • Pregnancy or lactation (less than 3 months since delivery, abortion, or lactation before start of treatment)
  • Hypersensitivity to any ingredient of the study drug
  • Any condition requiring immediate blood transfusion
  • Any diseases, conditions, or medications that can compromise the function of the body systems and could result in altered absorption, excessive accumulation, impaired metabolism, or altered excretion of the study drug
  • Any diseases or conditions that might interfere with the conduct of the study or the interpretation of the results
  • Abuse of alcohol, drugs, or medicines (e.g., laxatives)
  • Use of other treatments that might interfere with the conduct of the study or the interpretation of the results
  • Undiagnosed abnormal genital bleeding

Key Trial Info

Start Date :

March 30 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 12 2021

Estimated Enrollment :

153 Patients enrolled

Trial Details

Trial ID

NCT03476928

Start Date

March 30 2018

End Date

July 12 2021

Last Update

July 8 2022

Active Locations (25)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (25 locations)

1

Meitetsu Hospital

Nagoya, Aichi-ken, Japan, 451-8511

2

Kano's Clinic for Women

Nagoya, Aichi-ken, Japan, 460-0011

3

Kyoritsu Narashinodai Hospital

Funabashi, Chiba, Japan, 274-0063

4

Aso Iizuka Hospital

Iizuka, Fukuoka, Japan, 820-8505